Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents

Journal of Antimicrobial Chemotherapy

Volumn 56, Issue 2, 2005, Pages 407-409

  Smith, A J ^a   Hall, V ^b   Thakker, B ^c   Gemmell, C G ^d  

^a GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Actinomyces europaeus; Actinomyces funkei; Actinomyces gerencseriae; Actinomyces graevenitzii; Actinomyces israelii; Actinomyces turicensis; Antimicrobial susceptibility

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DNA 16S; DOXYCYCLINE; ERYTHROMYCIN; LINEZOLID; MEROPENEM; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE;

ACCURACY; ACTINOMYCES; ACTINOMYCES EUROPAEUS; ACTINOMYCES FUNKEI; ACTINOMYCES GERENCSERIAE; ACTINOMYCES GRAEVENITZII; ACTINOMYCES ISRAELII; ACTINOMYCES TURICENSIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; HUMAN; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RESTRICTION MAPPING; UNITED KINGDOM;

ACTINOMYCES; ACTINOMYCOSIS; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CROSS INFECTION; DNA, BACTERIAL; DNA, RIBOSOMAL; HUMANS; MICROBIAL SENSITIVITY TESTS; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S;

EID: 23844468932     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dki206     Document Type: Article

References (10)

1. Berardi R. Abdominal actinomycosis. Surg Gyn Obst 1979; 149: 257-66.
2. Benhoff DF. Actinomycosis: Diagnostic and therapeutic considerations and a review of 32 cases. Laryngo 1984; 94: 1198-1217.
3. Samuels RHA, Martin MV. A clinical and microbiological study of actinomycetes in oral and cervicofacial lesions. Br J Oral Maxillo Surg 1988; 26: 458-63.
4. Cintron JR, Del Pino A, Duarte B et al. Abdominal actinomycosis. Report of 2 cases and review of the literature. Dis Col Rect 1996; 39: 103-8.
5. Fiorino AS. Intrauterine contraceptive device-associated actinomycotic abscess and Actinomyces detection on cervical smear. Obst Gyn 1996; 87: 142-9.
6. Sabbe LJM, Van de Merwe D, Schouls L et al. Clinical spectrum of infections due to the newly described Actinomyces species A. turicensis, A. radingae and A. europaeus. J Clin Micro 1999; 37: 8-13.
7. Schaal KP, Pulverer G. Epidemiologic, etiologic, diagnostic, and therapeutic aspects of endogenous actinomycete infections. In: Ortiz-Ortiz L, Bojalil LF, Yakoleff V, eds. Biological, Biochemical, and Biomedical Aspects of Actinomycetes. Orlando, New York, London: Academic Press, 1984; 13-32.
8. Hall V, Talbot PR, Stubbs SL et al. Identification of clinical isolates of Actinomyces species by Amplified 16S Ribosomal DNA Restriction Analysis. J Clin Micro 2001; 39: 3555-62.
9. Hall V, Talbot P. Evaluation of the E-test for susceptibility testing of Actinomyces species. Rev Med Microbiol 1997; 8 (Suppl 1): S83.
10. Prather JR, Eastridge CE, Hughes FA et al. Actinomycosis of the thorax. diagnosis and treatment. Annals Thoracic Surg 1970; 9: 307-12.